Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 549.00
+9.00 (1.67%)
Jul 14, 2026, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 5.47 billion as of July 14, 2026. Its market cap has decreased by -27.30% in one year.
Market Cap
5.47B
Enterprise Value
3.17B
Revenue
234.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
549.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 5.47B, a decrease of -57.93%. That is a compound annual growth rate of -21.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.47B | -3.54% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mizuho Medy | 31.47B |
| Fuso Pharmaceutical Industries,Ltd. | 18.51B |
| Pharma Foods International | 17.48B |
| Taiko Pharmaceutical | 13.37B |
| Wakamoto Pharmaceutical | 9.67B |
| Morishita Jintan | 8.88B |
| Solasia Pharma K.K. | 7.37B |
| WDB coco | 6.25B |